Correlation between chemical structure and biological activities of Porphyromonas gingivalis synthetic lipopeptide derivatives

Clinical and Experimental Immunology

Volumn 146, Issue 1, 2006, Pages 159-168

  Makimura, Y ^a   Asai, Y ^a   Taiji, Y ^a   Sugiyama, A ^a   Tamai, R ^a   Ogawa, T ^a  

^a ASAHI UNIVERSITY   (Japan)

Author keywords

Lipoprotein; Porphyromonas gingivalis; Stereoisomer; Synthetic lipopeptide; Toll like receptor

Indexed keywords

CYSTEINE; CYTOKINE; FATTY ACID; GLYCEROL DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOPEPTIDE; N PENTADECANOYL DERIVATIVE; PEPTIDE; PROTEIN DERIVATIVE; S GLYCERO 2 PENTADECANOYL DERIVATIVE; S GLYCERO 3 PENTADECANOYL DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; HOST CELL; HUMAN; HUMAN EXPERIMENT; MALE; NONHUMAN; NORMAL HUMAN; PERITONEUM MACROPHAGE; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; STEREOISOMERISM;

ADULT; ANIMALS; BACTERIAL PROTEINS; CELLS, CULTURED; FEMALE; HUMANS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LIPOPROTEINS; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, KNOCKOUT; NF-KAPPA B; PORPHYROMONAS GINGIVALIS; SIGNAL TRANSDUCTION; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; TOLL-LIKE RECEPTOR 1; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 6;

EID: 33748691037     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03182.x     Document Type: Article

References (39)

1. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr. Microbial complexes in subgingival plaque. J Clin Periodontol 1998; 25:134-44.
2. Holt SC, Ebersole J, Felton J, Brunsvold M, Kornman KS. Implantation of Bacteroides gingivalis in nonhuman primates initiates progression of periodontitis. Science 1988; 239:55-7.
3. Asai Y, Hashimoto M, Fletcher HM, Miyake K, Akira S, Ogawa T. Lipopolysaccharide preparation extracted from Porphyromonas gingivalis lipoprotein-deficient mutant shows a marked decrease in toll-like receptor 2-mediated signaling. Infect Immun 2005; 73:2157-63.
4. Darveau RP, Arbabi S, Garcia I, Bainbridge B, Maier RV. Porphyromonas gingivalis lipopolysaccharide is both agonist and antagonist for p38 mitogen-activated protein kinase activation. Infect Immun 2002; 70:1867-73.
5. Ogawa T, Asai Y, Hashimoto M et al. Cell activation by Porphyromonas gingivalis lipid A molecule through Toll-like receptor 4- and myeloid differentiation factor 88-dependent signaling pathway. Int Immunol 2002; 14:1325-32.
6. Ogawa T, Asai Y, Hashimoto M, Uchida H. Bacterial fimbriae activate human peripheral blood monocytes utilizing TLR2, CD14 and CD11a/CD18 as cellular receptors. Eur J Immunol 2002; 32:2543-50.
7. Sugiyama A, Uehara A, Iki K et al. Activation of human gingival epithelial cells by cell-surface components of black-pigmented bacteria: augmentation of production of interleukin-8, granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor and expression of intercellular adhesion molecule 1. J Med Microbiol 2002; 51:27-33.
8. Nair BC, Mayberry WR, Dziak R, Chen PB, Levine MJ, Hausmann E. Biological effects of a purified lipopolysaccharide from Bacteroides gingivalis. J Periodont Res 1983; 18:40-9.
9. Ogawa T. Immunobiological properties of chemically defined lipid A from lipopolysaccharide of Porphyromonas (Bacteroides) gingivalis. Eur J Biochem 1994; 219:737-42.
10. Kirikae T, Nitta T, Kirikae F et al. Lipopolysaccharides (LPS) of oral black-pigmented bacteria induce tumor necrosis factor production by LPS-refractory C3H/HeJ macrophages in a way different from that of Salmonella LPS. Infect Immun 1999; 67:1736-42.
11. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003; 21:335-76.
12. Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol 2005; 17:1-14.
13. Shimazu R, Akashi S, Ogata H et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med 1999; 189:1777-82.
14. Poltorak A, He X, Smirnova I et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282:2085-8.
15. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004; 4:499-511.
16. Heine H, Lien E. Toll-like receptors and their function in innate and adaptive immunity. Int Arch Allergy Immunol 2003; 130:180-92.
17. Netea MG, van Deuren M, Kullberg BJ, Cavaillon JM, Van der Meer JW. Does the shape of lipid A determine the interaction of LPS with Toll-like receptors? Trends Immunol 2002; 23:135-9.
18. Reife RA, Coats SR, Al-Qutub M et al. Porphyromonas gingivalis lipopolysaccharide lipid A heterogeneity: differential activities of tetra- and penta-acylated lipid A structures on E-selectin expression and TLR4 recognition. Cell Microbiol 2006; 8:857-68.
19. Braun V. Covalent lipoprotein from the outer membrane of Escherichia coli. Biochim Biophys Acta 1975; 415:335-77.
20. Muhlradt PF, Meyer H, Jansen R. Identification of S-(2,3-dihydroxypropyl) cysteine in a macrophage-activating lipopeptide from Mycoplasma fermentans. Biochemistry 1996; 35:7781-6.
21. Takeuchi O, Kawai T, Muhlradt PF et al. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int Immunol 2001; 13:933-40.
22. Takeuchi O, Sato S, Horiuchi T et al. Cutting edge. role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol 2002; 169:10-4.
23. Hashimoto M, Asai Y, Ogawa T. Separation and structural analysis of lipoprotein in a lipopolysaccharide preparation from Porphyromonas gingivalis. Int Immunol 2004; 16:1431-7.
24. Takeuchi O, Hoshino K, Kawai T, et al. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and gram-positive bacterial cell wall components. Immunity 1999; 11:443-51.
25. Imoto M, Yoshimura N, Kusumoto S, Shiba T. Total synthesis of lipid A, active principle of bacterial endotoxin. Proc Jpn Acad Series B 1984; 60:285-8.
26. Roth A, Espuelas S, Thumann C, Frisch B, Schuber F. Synthesis of thiol-reactive lipopeptide adjuvants. Incorporation into liposomes and study of their mitogenic effect on mouse splenocytes. Bioconjug Chem 2004; 15:541-53.
27. Hashimoto M, Asai Y, Ogawa T. Treponemal phospholipids inhibit innate immune responses induced by pathogen-associated molecular patterns. J Biol Chem 2003; 278:44205-13.
28. Abraham E. NF-κB activation. Crit Care Med 2000; 28:N100-4.
29. Into T, Fujita M, Okusawa T, Hasebe A, Morita M, Shibata K. Synergic effects of mycoplasmal lipopeptides and extracellular ATP on activation of macrophages. Infect Immun 2002; 70:3586-91.
30. Metzger JW, Beck-Sickingeer AG, Loleit M, Eckert M, Besseler GG, Juang G. Synthetic S-(2,3-dihydroxypropyl) -cysteinyl peptides derived from the N terminus of the cytrochrome subunit of the photoreaction center of Rhodopseudomonas viridis enhance murine splenocyte proliferation. J Peptide Sci 1996; 3:184-90.
31. Stryer L. Biochemistry (illustrated), 2nd edn. New York: W.H. Freeman Co., 1981.
32. Langford MP, Chen D, Welbourne TC, Redens TB, Ganley JP. Stereo-isomer specific induction of renal cell apoptosis by synthetic muramyl dipeptide (N-acetylmuramyl-l-alanyl-d-isoglutamine). Mol Cell Biochem 2002; 236:63-73.
33. Takeuchi O, Kaufmann A, Grote K et al. Cutting edge. preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a Toll-like receptor 2- and MyD88-dependent signaling pathway. J Immunol 2000; 164:554-7.
34. Akashi S, Nagai Y, Ogata H et al. Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition. Int Immunol 2001; 13:1595-9.
35. Lien E, Means TK, Heine H et al. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin Invest 2000; 105:497-504.
36. Poltorak A, Ricciardi-Castagnoli P, Citterio S, Beutler B. Physical contact between lipopolysaccharide and Toll-like receptor 4 revealed by genetic complementation. Proc Natl Acad Sci USA 2000; 97:2163-7.
37. Grabiec A, Meng G, Fichte S, Bessler W, Wagner H, Kirschning CJ. Human but not murine Toll-like receptor 2 discriminates between tri-palmitoylated and tri-lauroylated peptides. J Biol Chem 2004; 279:48004-12.
38. Buwitt-Beckmann U, Heine H, Wiesmuller KH et al. Toll-like receptor 6-independent signaling by diacylated lipopeptides. Eur J Immunol 2005; 35:282-9.
39. Buwitt-Beckmann U, Heine H, Wiesmuller KH et al. TLR1- and TLR6-independent recognition of bacterial lipopeptides. J Biol Chem 2006; 281:9049-57.